The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors
Abstract
OBJECTIVES: Quality of life is reduced in inflammatory bowel disease (IBD). Whether or not this is true in IBD patients in long-standing remission is unclear. Symptoms compatible with irritable bowel syndrome (IBS) are common in IBD patients in remission. The importance of psychological factors in this process is a matter of controversy. METHODS: Forty-three patients with ulcerative colitis (UC) and 40 with Crohn’s disease (CD), who had been in remission for at least 1 yr according to laboratory parameters and clinical and endoscopical appearance, were included. These patients completed four different self-administered questionnaires, evaluating GI symptoms, anxiety, depression, and psychological general well-being. The two patient groups were compared with the general population, and within-group comparisons in psychometric scores were made between patients with and without IBS-like symptoms. RESULTS: The psychological well-being in IBD patients in long-standing remission was similar to that of the general population, despite the presence of more severe GI symptoms. CD patients reported more psychosocial dysfunction, reduced well-being, and GI symptoms than UC patients. Thirty-three percent of UC patients and 57% of CD patients had IBS-like symptoms. The group with IBS-like symptoms (both UC and CD) had higher levels of anxiety and depression and more reduced well-being than those without. Anxiety and reduced vitality were found to be independent predictors for IBS-like symptoms in these patients. CONCLUSION: The prevalence of IBS-like symptoms in IBD patients in long-standing remission is two to three times higher than that in the normal population. Psychological factors seem to be of importance in this process. However, as a group IBD patients in remission demonstrate psychological well-being comparable to that of the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Assche, G. V., Dignass, A. U., Panés, J., Beaugerie, L., Karagiannis, J. A., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E. J., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,444
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Self-citationPathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
Öhman, L., & Simrén, M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.4 · Cited by 617
Self-citationHalpin, S. J., & Ford, A. C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.260 · Cited by 607
Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20873 · Cited by 586
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 566
Assche, G. V., Dignass, A. U., Bokemeyer, B., Danese, S., Gionchetti, P., Moser, G., Beaugerie, L., Gomollón, F., Häuser, W., Herrlinger, K. R., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.09.005 · Cited by 474
Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437
Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—part II
Knowles, S. R., Keefer, L., Wilding, H., Hewitt, C., Graff, L. A., & Mikocka-Walus, A. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy015 · Cited by 416
Cremon, C., Gargano, L., Morselli-Labate, A. M., Santini, D., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Corinaldesi, R., & Barbara, G. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.94 · Cited by 342
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Renzulli, P., & Seibold, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20986 · Cited by 324
Martín, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., Sokol, H., Theodorou, V., Bercik, P., Verdu, E. F., et al. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0400-1 · Cited by 309
Pain and inflammatory bowel disease.
Bielefeldt, K., Davis, B., & Binion, D. G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20848 · Cited by 304
Graff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Jakul, L., McPhail, C., Ediger, J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.027 · Cited by 292
Chang, J., Leong, R. W., Wasinger, V. C., Ip, M., Yang, M., & Phan, T. G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.056 · Cited by 286
Farrokhyar, F., Marshall, J. K., Easterbrook, B., & Irvine, J. E. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195391.49762.89 · Cited by 310
Henriksen, M., Jahnsen, J., Lygren, I., Sauar, J., Kjellevold, Y., Schulz, T. B., Vatn, M. H., & Moum, B. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000225339.91484.fc · Cited by 267
Keohane, J., O’Mahony, C., O’Mahony, L., O’Mahony, S. M., Quigley, E. M. M., & Shanahan, F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.156 · Cited by 260
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
Vavricka, S. R., Spigaglia, S. M., Rogler, G., Pittet, V. E. H., Michetti, P., Felley, C. P., Mottet, C., Braegger, C., Rogler, D., Straumann, A., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21719 · Cited by 245
Minderhoud, I. M., Oldenburg, B., Wismeijer, J. A., Henegouwen, G. P. V. B., & Smout, A. J. P. M. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000020506.84248.f9 · Cited by 243
Romberg-Camps, M. J. L., Bol, Y., Dagnelie, P. C., Hesselink-van de Kruijs, M. A. M., Kester, A. D. M., Engels, L. G. J. B., van Deursen, C., Hameeteman, W. H. A., Pierik, M., Wolters, F., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21285 · Cited by 240
European evidence-based Consensus on the management of ulcerative colitis: Special situations
Biancone, L., Michetti, P., Travis, S. P. L., Escher, J. C., Moser, G., Forbes, A., Hoffmann, J. C., Dignass, A. U., Gionchetti, P., Jantschek, G., et al. (2008) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2007.12.001 · Cited by 236
The immune system in irritable bowel syndrome
Barbara, G., Cremon, C., Carini, G., Bellacosa, L., Zecchi, L., Giorgio, R. D., Corinaldesi, R., & Stanghellini, V. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.4.349 · Cited by 211
“Interestingly, IBS-like symptoms in patients with IBD were significantly associated to the presence of psychological impairment and poor quality of life.(22,23) IBD is thought to result”
Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
Pedersen, N. K., Ankersen, D. V., Felding, M., Wachmann, H., Végh, Z., Molzen, L., Burisch, J. M., Andersen, J. R., & Munkholm, P. S. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i18.3356 · Cited by 210
Colombel, J., Shin, A., & Gibson, P. R. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.001 · Cited by 209
Wacklin, P., Laurikka, P., Lindfors, K., Collin, P., Salmi, T. T., Lähdeaho, M., Saavalainen, P., Mäki, M., Mättö, J., Kurppa, K., et al. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.355 · Cited by 206
Goodhand, J. R., Wahed, M., Mawdsley, J. E., Farmer, A. D., Aziz, Q., & Rampton, D. S. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22916 · Cited by 234
Gut hormones: emerging role in immune activation and inflammation
Khan, W. I., & Ghia, J. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04150.x · Cited by 184
Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?
Singh, S., Graff, L. A., & Bernstein, C. N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.15 · Cited by 181
Mikocka-Walus, A. A., Turnbull, D. A., Moulding, N. T., Wilson, I. G., Andrews, J. M., & Holtmann, G. J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20062 · Cited by 178
Dignass, A. U., Preiß, J., Aust, D., Autschbach, F., Ballauff, A., Barretton, G., Bokemeyer, B., Fichtner‐Feigl, S., Hagel, S., Herrlinger, K. R., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1281666 · Cited by 179
Influences and impact of anxiety and depression in the setting of inflammatory bowel disease
Navabi, S., Gorrepati, V. S., Yadav, S., Chintanaboina, J., Maher, S., Demuth, P., Stern, B., Stuart, A., Tinsley, A., Clarke, K., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy143 · Cited by 172
Panara, A. J., Yarur, A. J., Rieders, B., Proksell, S., Deshpande, A. R., Abreu, M. T., & Sussman, D. A. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12669 · Cited by 168
T-Cell Activation in Patients With Irritable Bowel Syndrome
Öhman, L., Isaksson, S., Lindmark, A.-C., Posserud, I., Stotzer, P.-O., Strid, H., Sjövall, H., & Simrén, M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.116 · Cited by 165
Self-citationAnxiety and depression in patients with inflammatory bowel disease
Häuser, W., Janke, K.-H., Klump, B., & Hinz, A. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21346 · Cited by 163
Targownik, L. E., Sexton, K. A., Bernstein, M. T., Beatie, B., Sargent, M., Walker, J. R., & Graff, L. A. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.147 · Cited by 157
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome
Öhman, L., & Simrén, M. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.10.014 · Cited by 155
Self-citationBuchman, A. L., Katz, S., Fang, J. C., Bernstein, C. N., & Abou‐Assi, S. G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21117 · Cited by 145
Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases
Regueiro, M., Greer, J. B., & Szigethy, E. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.036 · Cited by 142
Burgmann, T., Clara, I., Graff, L., Walker, J., Lix, L., Rawsthorne, P., McPhail, C., Rogala, L., Miller, N., & Bernstein, C. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.003 · Cited by 135
Berrill, J. W., Sadlier, M., Hood, K., & Green, J. T. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.01.018 · Cited by 123
Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients
Schoepfer, A. M., Schaffer, T., Seibold‐schmid, B., Müller, S., & Seibold, F. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01166.x · Cited by 120
Peters, S. L., Muir, J. G., & Gibson, P. R. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13202 · Cited by 113
The overlap between irritable bowel syndrome and organic gastrointestinal diseases
Aziz, I., & Simrén, M. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30212-0 · Cited by 116
Self-citationThe Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases
Peppas, S., Pansieri, C., Piovani, D., Danese, S., Peyrin‐Biroulet, L., Tsantes, A. G., Brunetta, E., Tsantes, A. Ε., & Bonovas, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030377 · Cited by 116
Pain management in patients with inflammatory bowel disease: insights for the clinician
Srinath, A. I., Walter, C., Newara, M. C., & Szigethy, E. M. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12446158 · Cited by 111
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease
Ancona, A., Petito, C., Iavarone, I., Petito, V., Galasso, L., Leonetti, A., Turchini, L., Belella, D., Ferrarese, D., Addolorato, G., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.11.026 · Cited by 115
Drug Management of Visceral Pain: Concepts from Basic Research
Davis, M. P. (2012) · Pain Research and Treatment · doi:10.1155/2012/265605 · Cited by 104
Psychotherapy with chronic inflammatory bowel disease patients: A Review
von Wietersheim, J., & Kessler, H. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000236925.87502.e0 · Cited by 103
Adam, B., Liebregts, T., Gschossmann, J. M., Krippner, C., Scholl, F., Ruwe, M., & Holtmann, G. (2006) · Pain · doi:10.1016/j.pain.2006.02.029 · Cited by 101
Narcotic use for inflammatory bowel disease and risk factors during hospitalization
Long, M. D., Barnes, E. L., Herfarth, H. H., & Drossman, D. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21806 · Cited by 100
Nutritional Treatment in Crohn’s Disease
Caio, G., Lungaro, L., Caputo, F., Zoli, E., Giancola, F., Chiarioni, G., GIORGIO, R. D., & Zoli, G. (2021) · Nutrients · doi:10.3390/nu13051628 · Cited by 103
Öhman, L., Isaksson, S., Lundgren, A., Simrén, M., & Sjövall, H. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00410-6 · Cited by 98
Self-citationTricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease
Iskandar, H. N., Cassell, B., Kanuri, N., Gyawali, C. P., Gutierrez, A., Dassopoulos, T., Ciorba, M. A., & Sayuk, G. S. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000049 · Cited by 96
A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease
Bodini, G., Zanella, C., Crespi, M., Pumo, S. L., Demarzo, M. G., Savarino, E. V., Savarino, V., & Giannini, E. G. (2019) · Nutrition · doi:10.1016/j.nut.2019.06.023 · Cited by 91
Urocortin 1 in Colonic Mucosa in Patients with Ulcerative Colitis
Saruta, M., Takahashi, K., Suzuki, T., Torii, A., Kawakami, M., & Sasano, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0195 · Cited by 93
Jonefjäll, B., Öhman, L., Simrén, M., & Strid, H. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000921 · Cited by 90
Self-citationStrategies to improve quality of life in adolescents with inflammatory bowel disease
Karwowski, C., Keljo, D. J., & Szigethy, E. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20919 · Cited by 89
Dietary management of IBD—insights and advice
Halmos, E. P., & Gibson, P. R. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.11 · Cited by 87
Bokemeyer, B., Hardt, J., Hüppe, D., Prenzler, A., Conrad, S., Düffelmeyer, M., Hartmann, P., Hoffstadt, M., Klugmann, T., Schmidt, C., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.02.014 · Cited by 87
An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease
Haskey, N., & Gibson, D. L. (2017) · Nutrients · doi:10.3390/nu9030259 · Cited by 89
Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?
Csekő, K., Beckers, A. B., Keszthelyi, D., & Helyes, Z. (2019) · Pharmaceuticals · doi:10.3390/ph12020048 · Cited by 85
Quigley, E. M. M. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15621230 · Cited by 89
Naliboff, B. D., Kim, S. E., Bolus, R. R., Bernstein, C. N., Mayer, E. A., & Chang, L. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.377 · Cited by 82
Shen, B., Fazio, V. W., Remzi, F. H., Bennett, A. E., Lavery, I. C., López, R., Brezinski, A., Sherman, K. K., Bambrick, M. L., & Lashner, B. A. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-0284-8 · Cited by 81
B‐cell activation in patients with irritable bowel syndrome (IBS)
öhman, L., Lindmark, A. ‐., Isaksson, S., Posserud, I., Strid, H., Sjövall, H., & Simrén, M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01272.x · Cited by 78
Self-citationGastrointestinal Symptoms in Celiac Disease Patients on a Long-Term Gluten-Free Diet
Laurikka, P., Salmi, T. T., Collin, P., Huhtala, H., Mäki, M., Kaukinen, K., & Kurppa, K. (2016) · Nutrients · doi:10.3390/nu8070429 · Cited by 78
Mikocka-Walus, A. A., Turnbull, D. A., Andrews, J. M., Moulding, N. T., Wilson, I. G., Harley, H. A., Hetzel, D. J., & Holtmann, G. J. (2008) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-4-15 · Cited by 76
Nutritional problems in inflammatory bowel disease: The patient perspective
Prince, A. C., Whelan, K., Moosa, A., Lomer, M. C. E., & Reidlinger, D. P. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.04.016 · Cited by 76
Faure, C. C., & Giguère, L. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20506 · Cited by 70
Bhandari, S., Larson, M. E., Kumar, N., & Stein, D. (2017) · Gut and Liver · doi:10.5009/gnl16347 · Cited by 66
Factors That Reduce Health-Related Quality of Life in Patients With Primary Sclerosing Cholangitis
Valle, M., Rahman, M., Lindkvist, B., Bjornsson, E. S., Chapman, R. W., & Kalaitzakis, E. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.025 · Cited by 66
The Overlap of Functional Abdominal Pain in Pediatric Crohn’s Disease
Zimmerman, L. A., Srinath, A. I., Goyal, A., Bousvaros, A., Ducharme, P., Szigethy, E., & Nurko, S. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182802a0a · Cited by 65
MacDermott, R. P. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20048 · Cited by 63
Management of stress in inflammatory bowel disease: a therapeutic option?
Goodhand, J., Wahed, M., & Rampton, D. S. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.55 · Cited by 58
Kim, E. S., Cho, K. B., Park, K. S., Jang, B. I., Kim, K. O., Jeon, S. W., Jung, M. K., Kim, E. Y., & Yang, C. H. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318266fff5 · Cited by 53
Understanding and Treating Abdominal Pain and Spasms in Organic Gastrointestinal Diseases
Makharia, G. K. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31821fbd82 · Cited by 53
Food avoidance in outpatients with Inflammatory Bowel Disease – Who, what and why
Marsh, A., Kinneally, J., Robertson, T., Lord, A., Young, A., & Radford‐Smith, G. L. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.03.018 · Cited by 53
Irritable pouch syndrome is characterized by visceral hypersensitivity
Shen, B., Sanmiguel, C. P., Bennett, A. E., Lian, L., Larive, B., Remzi, F. H., Fazio, V. W., & Soffer, E. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21412 · Cited by 52
Leone, D., Gilardi, D., Corrò, B. E., Menichetti, J., Vegni, E. A. M., Correale, C., Mariangela, A., Furfaro, F., Bonovas, S., Peyrin‐Biroulet, L., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy400 · Cited by 53
Kennedy, A. P., Robinson, A., Hann, M., Thompson, D. G., & Wilkin, D. (2003) · Health & Social Care in the Community · doi:10.1046/j.1365-2524.2003.00399.x · Cited by 52
Jelsness‐Jørgensen, L., Bernklev, T., & Moum, B. A. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/620707 · Cited by 51
Psychological factors and stress in inflammatory bowel disease
Triantafillidis, J. K., Merikas, E., & Gikas, A. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.13.4 · Cited by 50
IBS-Symptoms in IBD Patients—Manifestation of Concomitant or Different Entities
Szałwińska, P., Włodarczyk, J., Spinelli, A., Fichna, J., & Włodarczyk, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010031 · Cited by 49
Armuzzi, A., Assche, G. V., Reinisch, W., de Chambrun, G. P., Griffiths, A. M., Sładek, M., Preiß, J., Lukáš, M., & D’Haens, G. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.12.016 · Cited by 46
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission
Teruel, C. (2016) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v7.i1.78 · Cited by 47
Perera, L. P., Radigan, M., Guilday, C., Banerjee, I., Eastwood, D. C., Babygirija, R. P., & Massey, B. T. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05488-8 · Cited by 45
Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS)
El‐Salhy, M., Hatlebakk, J. G., & Hausken, T. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101973 · Cited by 47
Calvet, X., Gallardo, O., Coronas, R., Casellas, F., Montserrat, A., Torrejón, A., Vergara, M., Campo, R., & Brullet, E. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200608000-00004 · Cited by 45
Gluten‐Free Diet in IBD: Time for a Recommendation?
Weaver, K. N., & Herfarth, H. H. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901274 · Cited by 44
Adam, B., Liebregts, T., & Holtmann, G. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0717 · Cited by 44
Enteric ganglioneuritis and abnormal interstitial cells of Cajal
Ohlsson, B., VERESS, B., Lindgren, S. C., & Sundkvist, G. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20095 · Cited by 44
Özer, M., Bengı, G., Çolak, R., Cengiz, O., & Akpınar, H. (2020) · Medicine · doi:10.1097/md.0000000000020067 · Cited by 44
Kochar, B. D., Martin, C. F., Kappelman, M. D., Spiegel, B. M. R., Chen, W., Sandler, R. S., & Long, M. D. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.240 · Cited by 42
Wu, Y., Wang, Y., Wang, J., Fan, Q. W., Zhu, J., Liu, Y., & Rong, W. (2019) · Molecular Pain · doi:10.1177/1744806919830018 · Cited by 41
Jonefjäll, B., Simrén, M., Lasson, A., Öhman, L., & Strid, H. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617703868 · Cited by 40
Self-citationPreventing disability in inflammatory bowel disease
Allen, P. B., Gower‐Rousseau, C., Danese, S., & Peyrin‐Biroulet, L. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17732720 · Cited by 40
Lamers, C. R., de Roos, N. M., Koppelman, L. J. M., Hopman, M. T. E., & Witteman, B. J. M. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01739-z · Cited by 40
Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
Plavšić, I., Hauser, G., Tkalčić, M., Pletikosić, S., & Salkić, N. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/490183 · Cited by 37
Ahola Kohut, S., Stinson, J., Jelen, A., & Ruskin, D. (2020) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09622-6 · Cited by 38
Metadata
- Authors
- Simrén, M.
- Venue
- The American Journal of Gastroenterology
- Published
- 2002-02
- Volume
- 97
- Issue
- 2
- Pages
- 389-396
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W4231548066
- Cited by
- 186
- References
- 0
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 3 · 2023: 12 · 2022: 13 · 2021: 10 · 2020: 11 · 2019: 19 · 2018: 12 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 14
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Keywords
- inflammatory bowel disease, quality of life, IBS-like symptoms, ulcerative colitis, Crohn's disease, remission, anxiety, depression, psychological well-being, gastrointestinal symptoms, vitality, psychosocial dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review